Women’s Health, Aerobic Vaginitis, Vaginal Microbiome

Aerobic Vaginitis: The Vaginal Condition Most Women Have Never Heard Of

Aerobic vaginitis is one of the most commonly missed causes of recurrent vaginal symptoms. Often mistaken for bacterial vaginosis or thrush, it requires a completely different, investigation-led approach. In this article, I explain what it is, how it is identified, and why it matters for women in Australia living with ongoing discomfort.

I am Kylie Sayce, Nurse Practitioner in women’s intimate health. In my clinic, I regularly meet women who have been living with persistent or recurrent vaginal symptoms for months, sometimes years. Many have had multiple courses of treatment for bacterial vaginosis (BV) or thrush. Some have tried over-the-counter options, others have had repeated prescriptions for metronidazole, clindamycin, or antifungal creams and tablets. Despite all of this, their symptoms never fully settle, or they return within weeks.

When I take a detailed history, review previous results, and arrange comprehensive microbiome testing, a different picture often emerges. In a significant number of these women, the primary issue is not BV or thrush at all. Instead, the underlying problem is a condition called aerobic vaginitis (AV) — a form of vaginal dysbiosis that most women have never been told about, and that many clinicians are still becoming familiar with in everyday practice.

My aim in this article is educational. I will not be discussing specific treatment regimens or making promises about outcomes. Instead, I want to give you a clear, evidence-based understanding of what aerobic vaginitis is, how it differs from BV and thrush, and when it might be worth asking whether this condition has been considered in your own care.

What Is Aerobic Vaginitis?

Aerobic vaginitis is a vaginal condition characterised by three key features: an overgrowth of aerobic bacteria, a marked reduction in protective Lactobacillus species, and a heightened inflammatory response in the vaginal tissue. The vaginal pH is typically raised above the normal acidic range, which further favours the growth of less-friendly organisms. Research and clinical resources such as DermNetNZ describe AV as a distinct pattern of vaginal dysbiosis, with inflammation and atrophy often present alongside the microbial changes.

The term “aerobic” refers to bacteria that require oxygen to survive. This is an important distinction. Bacterial vaginosis is driven primarily by anaerobic bacteria — organisms that thrive in low-oxygen environments, such as Gardnerella vaginalis, Atopobium vaginae, and Prevotella species. Aerobic vaginitis, on the other hand, involves organisms that prefer oxygen-rich conditions. In practice, this means that the medications commonly prescribed for BV, particularly metronidazole, are not designed to target the aerobic organisms typically seen in AV, and may have limited impact on them.

The aerobic organisms most frequently associated with AV include:

• Escherichia coli (E. coli) — the most commonly identified organism in AV, and also the leading cause of urinary tract infections (UTIs).

• Streptococcus agalactiae (Group B Streptococcus).

• Staphylococcus aureus, including strains with significant resistance patterns in some recent studies.

• Enterococcus faecalis, which has been linked in some research with cervical changes in women who also have HPV.

• Klebsiella pneumoniae and other enteric organisms.

In AV, these bacteria are not just present at low background levels; they often dominate the vaginal environment in the context of severely depleted lactobacilli. The vaginal tissue is typically inflamed, sometimes atrophic, and the immune system is clearly activated. This inflammatory component is one of the key differences between AV and BV, and it often explains the burning, stinging, and pain that many women describe.

How Is Aerobic Vaginitis Different From Bacterial Vaginosis?

In everyday clinical practice, the distinction between AV and BV is often blurred, yet it is clinically crucial. Both conditions involve disruption of the normal vaginal microbiome and loss of protective lactobacilli, but the organisms involved, the immune response, and the typical symptoms differ in important ways. Misunderstanding these differences can lead to repeated, ineffective treatment attempts and ongoing distress for women.

In my clinic, it is not unusual to see a woman who has been treated several times for BV, with only partial or temporary relief, because the underlying issue is actually AV. The discharge may not fit the classic “thin, grey, fishy” description of BV. Instead, it may be yellow or green-tinged, with more pronounced burning, rawness, and pain during intercourse. When we investigate more deeply, the microbiome profile often reveals high levels of aerobic organisms and very low levels of lactobacilli, consistent with aerobic vaginitis rather than BV alone.

Why Is Aerobic Vaginitis So Commonly Missed?

Aerobic vaginitis is increasingly described in the research literature, yet it remains under-recognised in day-to-day practice. There are several reasons for this. First, the standard diagnostic tools used in many settings — such as Amsel criteria and Nugent scoring — were developed to identify BV, not AV. These tools focus on features typical of BV, such as clue cells and the balance between lactobacilli and anaerobes, and they do not directly measure the aerobic organisms or inflammatory changes seen in AV.

Second, symptoms of AV overlap significantly with those of BV and thrush. Discharge, odour, itching, and irritation can all occur in various combinations. When time is limited and access to advanced testing is constrained, it is understandable that clinicians may make a best-guess diagnosis based on the most common conditions. BV and thrush are familiar and frequently treated; AV is less widely discussed in training and standard guidelines, so it may not be top of mind when a woman presents with recurrent symptoms.

Third, a routine high vaginal swab, especially if it relies on standard culture methods, may not fully capture the complexity of the vaginal microbiome. Results may be reported as “normal flora,” “no growth,” or may list organisms without quantifying their load or placing them in the context of the overall microbial community. Aerobic organisms such as E. coli or Enterococcus may be noted but not interpreted as the primary driver of symptoms, particularly if the report is not linked with a structured scoring system like the aerobic vaginitis score described in specialist resources.

Finally, without access to comprehensive PCR-based microbiome testing, AV can be effectively invisible. In my clinical experience, when we move beyond standard swabs and perform detailed microbiome mapping, aerobic organisms — especially E. coli — often emerge as prominent findings in women with recurrent symptoms. This does not mean that every woman with these organisms has AV, but it does highlight how much more we can see when we use more sensitive, technology-enabled diagnostic tools.

The Connection Between Aerobic Vaginitis and Recurrent UTIs

For many women, recurrent vaginal symptoms do not occur in isolation. A common pattern I see is the combination of ongoing discharge, burning, and discomfort, alongside repeated bouts of urinary tract infections. This is where the link between aerobic vaginitis and UTIs becomes particularly important to understand.

E. coli is the most common cause of community-acquired UTIs, and it is also the most frequently identified aerobic organism in AV. When E. coli colonises the vaginal environment at high levels, the vagina can act as a reservoir. From there, bacteria can more easily reach the urethra and bladder, especially after sexual activity or in the presence of other risk factors. In women with both recurrent vaginal symptoms and recurrent UTIs, it is not unusual for the same organism to be involved in both sites.

This does not mean that every UTI is caused by AV, or that addressing the vaginal microbiome will automatically resolve urinary infections. However, it does suggest that, for some women, focusing solely on treating each UTI as it appears — with short courses of antibiotics — may not be enough. If the vaginal microbiome remains dominated by E. coli or other uropathogens, the risk of recurrence is likely to remain higher. Understanding and investigating this connection can be an important part of a more holistic, evidence-based approach to recurrent UTIs in women with coexisting vaginal symptoms.

Symptoms of Aerobic Vaginitis

Persistent vaginal discomfort, especially when standard treatments fail, can be a clue to deeper microbiome disruption.

One of the challenges with aerobic vaginitis is that its symptoms can mimic more familiar conditions. However, there are certain patterns that, in my experience, raise suspicion for AV, particularly when they occur together or persist despite treatment. Women with AV may report:

• Vaginal discharge that is yellow, green-tinged, or frankly purulent, rather than the thin grey-white discharge typical of BV or the cottage-cheese appearance seen in thrush.

• A burning or stinging sensation in the vagina or vulva, sometimes described as feeling “raw,” “sunburnt,” or “like sandpaper.”

• Vulval redness and irritation, with visible inflammation on examination.

• Pain or discomfort during sexual intercourse (dyspareunia), sometimes leading to avoidance of intimacy due to fear of pain or post-coital flares.

• Vaginal soreness that persists even between obvious “flare-ups,” suggesting an ongoing inflammatory process rather than isolated episodes.

• Elevated vaginal pH (above 4.5), when this is measured in clinic or as part of testing.

• Symptoms that do not resolve, or only partially improve, with standard BV or thrush treatment, or that return very quickly after treatment ends.

It is also important to note that AV can coexist with BV, thrush, or other infections. Mixed infections are common in real life, and they can make diagnosis and management more complex. For example, a woman may have a positive test for Candida and receive antifungal treatment, which improves some symptoms but leaves burning and discharge unresolved because an underlying aerobic vaginitis pattern has not been identified. This is one of the reasons why I place strong emphasis on comprehensive assessment rather than assuming a single organism explains everything.

How Is Aerobic Vaginitis Identified?

Detailed microbiome testing can reveal patterns that standard swabs simply do not show.

Proper identification of aerobic vaginitis requires more than a quick look at symptoms or a basic swab. In specialist settings, the gold standard described in the literature is wet-mount microscopy with an aerobic vaginitis score, taking into account lactobacillary grade, leukocyte numbers and toxicity, presence of parabasal cells, and the type of microflora present. In many Australian primary care settings, this level of microscopy is not routinely available, which is one reason AV can be missed.

In my practice, I use a combination of approaches to build a clear picture:

• Comprehensive PCR vaginal microbiome testing — This technology-based testing can identify a wide range of organisms, including aerobic and anaerobic bacteria, yeasts, and sometimes viruses, and can provide information on relative abundance or load. It allows us to see whether organisms such as E. coli, Enterococcus, or Staphylococcus are present at levels consistent with AV, and whether protective Lactobacillus species are depleted.

• Vaginal pH measurement — AV is consistently associated with an elevated pH, usually above 4.5. Simple pH testing in clinic can provide a quick, low-cost data point that, while not diagnostic on its own, helps to differentiate between conditions and track change over time.

• Assessment of Lactobacillus levels — Whether via microscopy or PCR, determining the presence and dominance of lactobacilli is central. In AV, these are almost always significantly reduced, with other organisms occupying the ecological niche that lactobacilli would normally hold.

• Inflammatory markers and tissue changes — Where available, microscopic assessment may reveal increased leukocytes and parabasal cells, indicating inflammation and sometimes atrophy. Clinically, this often correlates with the burning, soreness, and dyspareunia women describe.

• Detailed symptom and history-taking — I pay close attention to the character of discharge, the presence and timing of pain during sex, patterns around menstruation, prior antibiotic use, hygiene practices, and any history of recurrent UTIs. This context is essential for interpreting laboratory findings meaningfully.

A key point is that standard high vaginal swabs reported as “no growth” or “normal flora” do not reliably exclude AV. Culture-based methods have limitations, and they may fail to grow or quantify organisms that are clearly present on molecular testing. For women with ongoing symptoms, a “normal” swab result should be seen as one piece of information, not the final word.

What Aerobic Vaginitis Tells Us About the Vaginal Environment

One of the most important shifts in women’s health over the past decade has been the move from thinking of vaginal conditions as isolated infections to understanding them as expressions of a broader microbiome imbalance. Aerobic vaginitis is a clear example of this. Like BV, AV is not simply “caught” in the same way as an acute infection; it arises in the context of a disrupted vaginal ecosystem where protective lactobacilli have been lost and other organisms have taken their place.

In both BV and AV, severe depletion of Lactobacillus species is a central feature. Lactobacilli normally help to maintain an acidic pH, produce antimicrobial substances such as lactic acid and hydrogen peroxide, and create a physical and biochemical barrier against less-friendly microbes. When these protective bacteria are diminished — whether through antibiotic exposure, hormonal changes, local irritants, or other factors — the vaginal environment becomes more hospitable to opportunistic organisms, including both anaerobes and aerobes.

In AV, this shift is accompanied by a pronounced inflammatory response. The immune system recognises that the vaginal tissue is under threat and responds with increased white blood cells, cytokines, and sometimes structural changes in the epithelium. Women experience this as burning, stinging, and pain. From a clinical perspective, this means that any management plan needs to consider not only the presence of specific aerobic organisms, but also the inflammatory and hormonal environment, and the longer-term goal of restoring lactobacillus-dominant flora.

Current literature and expert consensus emphasise that focusing solely on suppressing the acute aerobic overgrowth, without addressing the underlying dysbiosis, is likely to result in recurrence. While I will not discuss specific products or regimens here, the general principle is that microbiome restoration — often involving lifestyle factors, careful choice of medications, and sometimes probiotic strategies — sits alongside targeted treatment of the identified organisms. This is an evolving area of research, and new data on probiotics and microbiome modulation continue to emerge.

When to Suspect Aerobic Vaginitis

Seeking a thorough assessment can be an empowering step when symptoms keep returning.

From a practical standpoint, when should aerobic vaginitis be on the radar? In my experience working with Australian women, I begin to strongly consider AV when I see the following patterns:

• Recurrent or persistent vaginal symptoms that have not fully resolved with standard BV or thrush treatments, or that return quickly after each treatment course.

• Discharge that is yellow or green-tinged, sometimes thick or purulent, rather than the classic thin grey-white discharge of BV or the lumpy, white discharge of candida.

• Significant burning, irritation, or dyspareunia alongside discharge — particularly when the level of pain seems out of proportion to what we would expect with BV alone.

• A history of recurrent UTIs occurring in parallel with vaginal symptoms, especially when E. coli is repeatedly identified in urine cultures.

• “Normal” or negative standard swab results, despite ongoing symptoms that are clearly affecting quality of life and sexual wellbeing.

• Vaginal pH consistently above 4.5, when this has been measured, suggesting a shift away from a lactobacillus-dominant, acidic environment.

None of these features, on their own, prove that AV is present. Many conditions can cause similar symptoms. However, when several of these clues appear together — particularly in the context of repeated BV or thrush treatments that have not been fully effective — it is reasonable to ask whether aerobic vaginitis has been considered, and whether more detailed microbiome assessment might be appropriate.

Closing Thoughts and Next Steps

Understanding your diagnosis is a powerful foundation for making informed decisions about your health.

Many women living with aerobic vaginitis have never been told that this condition exists. They have been reassured that results are “normal,” or they have been treated repeatedly for BV or thrush without lasting relief. This is understandably frustrating and can take a real toll on confidence, relationships, and overall wellbeing. Recognising that AV is a distinct clinical entity — different from BV, driven by aerobic organisms, and associated with a strong inflammatory response — is an important step toward more accurate diagnosis and tailored care.

From a clinical perspective, aerobic vaginitis reminds us that the vaginal environment is complex and dynamic. It is not enough to focus on a single organism or a single treatment. Instead, we need to consider the whole microbiome, the integrity of the tissue, hormonal influences, sexual and urinary health, and the woman’s lived experience of her symptoms. Emerging research continues to refine our understanding of AV, including its links with recurrent UTIs, cervical health, and antimicrobial resistance patterns. At the same time, there are still gaps in formal guidelines, and management remains individualised, guided by available evidence and careful clinical judgment.

As a Nurse Practitioner, my role is to provide thorough assessment, clear education, and collaborative care planning. I do not make guarantees about outcomes, and I do not recommend one-size-fits-all solutions. What I can offer is time to listen to your story, access to comprehensive microbiome testing where appropriate, and a structured, evidence-informed framework for understanding recurrent vaginal symptoms — including the possibility of aerobic vaginitis when the pattern fits.

📌 Key Takeaway: If you are an Australian woman experiencing recurrent vaginal symptoms, BV or thrush that keeps returning, or a combination of vaginal discomfort and recurrent UTIs, it may be worth exploring whether aerobic vaginitis and broader vaginal microbiome disruption are part of the picture.

If you would like a comprehensive, nurse practitioner-led assessment of your intimate health, including discussion of aerobic vaginitis symptoms in Australia, aerobic vaginitis vs BV, and the role of investigation-based care, you are welcome to book an initial consultation with me. Consultations are educational and collaborative, and any decisions about investigations or management are made together, based on your goals and the available evidence.

Whether you choose to work with my clinic or another trusted practitioner, I encourage you not to dismiss persistent vaginal symptoms as “just BV” or “just thrush” when they keep returning. Your comfort, sexual health, and quality of life matter, and you deserve a careful, thorough, and respectful approach to finding out what is really going on.